These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7875639)
1. Effects of dipyridamole, soluflazine and related molecules on adenosine uptake and metabolism by isolated human red blood cells. Ferrandon P; Barcelo B; Perche JC; Schoffs AR Fundam Clin Pharmacol; 1994; 8(5):446-52. PubMed ID: 7875639 [TBL] [Abstract][Full Text] [Related]
2. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes. Kalsi KK; Smolenski RT; Yacoub MH Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646 [TBL] [Abstract][Full Text] [Related]
3. Dipyridamole inhibition of adenosine metabolism in human blood. Klabunde RE Eur J Pharmacol; 1983 Sep; 93(1-2):21-6. PubMed ID: 6628545 [TBL] [Abstract][Full Text] [Related]
4. Relationship between adenosine deaminase activity (ADA) and inosinemonophosphate (IMP) accumulation in fresh erythrocytes incubated with adenosine and dipyridamole. Kopff M; Zakrzewska I; Klem J; Strzelczyk M Haematologia (Budap); 1989; 22(3):161-7. PubMed ID: 2583595 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity. Gresele P; Arnout J; Deckmyn H; Vermylen J Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of adenosine uptake in human erythrocytes by adenosine-5'-carboxamides, xylosyladenine, dipyridamole, hexobendine, and p-nitrobenzylthioguanosine. Turnheim K; Plank B; Kolassa N Biochem Pharmacol; 1978; 27(18):2191-7. PubMed ID: 728171 [No Abstract] [Full Text] [Related]
7. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate. Plagemann PG J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996 [TBL] [Abstract][Full Text] [Related]
8. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine. Dawicki DD; Agarwal KC; Parks RE Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970 [TBL] [Abstract][Full Text] [Related]
9. Effect of dipyridamole on adenosine incorporation into hypoxanthine nucleotides of fresh human red cells. Kopff M; Zakrzewska I; Klem J; Zachara B Haematologia (Budap); 1986; 19(2):89-94. PubMed ID: 3758842 [TBL] [Abstract][Full Text] [Related]
10. Influence of hexobendine, dipyridamole, dilazep, lidoflazine, inosine and purine riboside on adenosine uptake by the isolated epithelium of guinea pig jejunum. Kolassa N; Stengg R; Turnheim K Pharmacology; 1978; 16(1):54-60. PubMed ID: 619363 [TBL] [Abstract][Full Text] [Related]
11. Some effects of dipyridamole, hexobendine and lidoflazine on inhibitory processes in rabbit duodenum. Hulme ME; Weston AH Br J Pharmacol; 1974 Apr; 50(4):609-11. PubMed ID: 4447864 [TBL] [Abstract][Full Text] [Related]
12. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine. Plagemann PG; Woffendin C Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106 [TBL] [Abstract][Full Text] [Related]
13. Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex. Phillis JW; O'Regan MH; Walter GA Brain Res; 1989 Mar; 481(2):309-16. PubMed ID: 2720383 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine. Pirovano IM; Van Belle H; Ijzerman AP Eur J Pharmacol; 1990 Dec; 189(6):419-22. PubMed ID: 2073930 [TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of nucleoside transport systems in mammalian cells by a new series of compounds related to lidoflazine and mioflazine. Griffith DA; Conant AR; Jarvis SM Biochem Pharmacol; 1990 Nov; 40(10):2297-303. PubMed ID: 2244931 [TBL] [Abstract][Full Text] [Related]
16. Calcium entry blocking activity of dilazep and other adenosine potentiating compounds in guinea-pig atria. Nakagawa Y; Gudenzi M; Mustafa SJ Eur J Pharmacol; 1986 Mar; 122(1):51-8. PubMed ID: 3956577 [TBL] [Abstract][Full Text] [Related]
17. Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole. Kolassa N; Pfleger K Biochem Pharmacol; 1975 Jan; 24(1):154-6. PubMed ID: 1168469 [No Abstract] [Full Text] [Related]
18. Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. van Giezen JJ; Sidaway J; Glaves P; Kirk I; Björkman JA J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):164-72. PubMed ID: 21697355 [TBL] [Abstract][Full Text] [Related]
19. [Inhibition of adenosine incorporation by dipyridamole: influence on 2,3 diphosphoglycerate metabolism in human erythrocytes]. Pinilla M; Luque J; Santos-Ruiz A Ann Pharm Fr; 1973; 31(7):503-12 passim. PubMed ID: 4793460 [No Abstract] [Full Text] [Related]
20. Mechanism of enchancement of adenosine action by dipyridamole and lidoflazine, in dogs. Afonso S; O'Brien GS Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):181-96. PubMed ID: 5123865 [No Abstract] [Full Text] [Related] [Next] [New Search]